Does HER-2 status predict only a decreased response to hormone therapy in advanced breast cancer, or does it also predict the extent of metastatic disease? [1] (multiple letters)

Miquel Beltràn; Ramon Colomer; Allan Lipton; S. M. Ali; K. Leitzel

doi:10.1200/JCO.2002.99.191

Does HER-2 status predict only a decreased response to hormone therapy in advanced breast cancer, or does it also predict the extent of metastatic disease? [1] (multiple letters)

Miquel Beltràn, Ramon Colomer, Allan Lipton, S. M. Ali, K. Leitzel

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	4605-4606
Number of pages	2
Journal	Journal of Clinical Oncology
Volume	20
Issue number	23
DOIs	https://doi.org/10.1200/JCO.2002.99.191
State	Published - Dec 1 2002

All Science Journal Classification (ASJC) codes

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1200/JCO.2002.99.191

Cite this

@article{b7386785744440fbb53321d082684b25,

title = "Does HER-2 status predict only a decreased response to hormone therapy in advanced breast cancer, or does it also predict the extent of metastatic disease? [1] (multiple letters)",

author = "Miquel Beltr{\`a}n and Ramon Colomer and Allan Lipton and Ali, {S. M.} and K. Leitzel",

year = "2002",

month = dec,

day = "1",

doi = "10.1200/JCO.2002.99.191",

language = "English (US)",

volume = "20",

pages = "4605--4606",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "23",

}

Does HER-2 status predict only a decreased response to hormone therapy in advanced breast cancer, or does it also predict the extent of metastatic disease? [1] (multiple letters). / Beltràn, Miquel; Colomer, Ramon; Lipton, Allan et al.
In: Journal of Clinical Oncology, Vol. 20, No. 23, 01.12.2002, p. 4605-4606.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Does HER-2 status predict only a decreased response to hormone therapy in advanced breast cancer, or does it also predict the extent of metastatic disease? [1] (multiple letters)

AU - Beltràn, Miquel

AU - Colomer, Ramon

AU - Lipton, Allan

AU - Ali, S. M.

AU - Leitzel, K.

PY - 2002/12/1

Y1 - 2002/12/1

UR - http://www.scopus.com/inward/record.url?scp=0036894047&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036894047&partnerID=8YFLogxK

U2 - 10.1200/JCO.2002.99.191

DO - 10.1200/JCO.2002.99.191

M3 - Letter

C2 - 12454123

AN - SCOPUS:0036894047

SN - 0732-183X

VL - 20

SP - 4605

EP - 4606

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 23

ER -

Does HER-2 status predict only a decreased response to hormone therapy in advanced breast cancer, or does it also predict the extent of metastatic disease? [1] (multiple letters)

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Cite this